$8.47
0.121.44%
At Close: -
$8.43
-0.04-0.47%
After Hours: 7:59 PM EDT
15 minutes delayed
Emergent BioSolutions reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Emergent BioSolutions using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $-2.32 | $-0.94 | -146.8 % |
Mar 2024 | 2024-05-01 | $0.59 | $-0.83 | 171.1 % |
Dec 2023 | 2024-03-06 | $-0.77 | $-0.19 | -305.3 % |
Sep 2023 | 2023-11-08 | $-0.87 | $-0.22 | -295.4 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $254.70M | $190.00M | 34.1 % |
Mar 2024 | 2024-05-01 | $300.40M | $224.50M | 33.8 % |
Dec 2023 | 2024-03-06 | $276.60M | $293.53M | -5.77 % |
Sep 2023 | 2023-11-08 | $270.50M | $237.43M | 13.9 % |
Emergent BioSolutions (EBS) is scheduled to report earnings on October 31, 2024. The last reported earnings were for reported on August 6, 2024 for Q2.
The Actual EPS was $-2.32, which missed the estimate of $-0.94.
The Actual Revenue was $254.7M, which beat the estimate of $190M.
Browse earnings estimates, EPS, and revenue on all stocks.